Numakura Kazuyuki

ヌマクラカズユキ | Numakura Kazuyuki

Affiliation and department：
Job title： Lecturer
Research theme for competitive and other funds (8)：

2021 - 2025 Molecular mechanisms and target molecules associated with progression and treatment resistance of urologic cancers associated with microbiome alterations by diet and obesity
2021 - 2024 低分子cfDNAを指標とした腎細胞癌の早期の新規・再発診断および治療効果判定
2020 - 2023 腎細胞癌における脂肪由来幹細胞の役割の解明と新たな治療戦略の開発
2017 - 2021 Cancer stem cell characteristics in mTOR inhibitor-resistant kidney cancer cells
2016 - 2021 Molecular analysis and delineation of the mechanisms underlying progression of urogenital cancers and alteration of tumor immuno-microenvironment associated with adiposity enhancement

Show all

Papers (101)：

Sekine Y. Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese. Japanese journal of clinical oncology. 2022. 52. 12. 1441-1445
Numakura K. Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon’s experience. World Journal of Surgical Oncology. 2022. 20. 1
Yagishita H. Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients. International Journal of Molecular Sciences. 2022. 23. 19
Inoue T. Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG. Urology. 2022. 167. 158-164
SASAKI Yoshiki, KASHIMA Soki, KOYAMA Takashi, HIROSHIMA Yuko, AMANO Kenji, TAKAHASHI Syuhei, NARA Taketoshi, KOIZUMI Atsushi, YAMAMOTO Ryohei, NUMAKURA Kazuyuki, et al. A Case of Renal Anastomosing Hemangioma. 2022. 68. 8. 265-269

ｍore...

MISC (1)：

Tomita Y. Erratum: Subgroup analysis of the AFTER I-O study: A retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (Japanese Journal of Clinical Oncology (2021) DOI: 10.1093/jjco/hyab114). Japanese Journal of Clinical Oncology. 2021. 51. 12

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page